María Victoria
Mateos Manteca
Tata Medical Center
Calcuta, IndiaTata Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2020
-
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial
The Lancet, Vol. 396, Núm. 10262, pp. 1563-1573